Msn - Profile
✉ Email this page to a colleague
Drugs and US Patents for Msn
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Msn | DEFERASIROX | deferasirox | GRANULE;ORAL | 214650-001 | Mar 17, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Msn | CHLORPROMAZINE HYDROCHLORIDE | chlorpromazine hydrochloride | TABLET;ORAL | 214827-003 | Jan 27, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Msn | TASIMELTEON | tasimelteon | CAPSULE;ORAL | 211654-001 | Jan 12, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Msn | LACOSAMIDE | lacosamide | SOLUTION;ORAL | 215379-001 | Dec 22, 2023 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Msn | DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | TABLET;ORAL | 214823-002 | Apr 3, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |